In advance of the Agency's public workshop on Enhancing Adoption of Innovative Clinical Trial Approaches, BIO outlined specific considerations and plans to participate in the workshop.
COVID-19, flu, and RSV are here—but for the first winter ever, we have vaccines for all three. Meanwhile, USDA has awarded $19 million in grants to boost biofuels. (417 words, 2 minutes, 5 seconds)
BIO and the American Seed Trade Association submitted comments on USDA-APHIS' proposed exemptions of five types of genetic modifications a plant can contain and be exempt from regulations for the movement of organisms modified or produced through genetic engineering because the modifications could otherwise be achieved through conventional breeding.
Announcements around and during JPM Week each January often create waves throughout the biotechnology ecosystem. Join this webinar to learn what experienced dealmakers and market analysts found most relevant and influential from JPM Week to consider when planning your own capital formation and partnering priorities for 2024. Developments affecting M&A trends, the IPO window, licensing trends, and investor sentiment will all be discussed.
This webinar will also preview the program for the BIO CEO & Investor Conference, February 26-27, and explain how BIO’s One-on-One Partnering during the event can help you make progress against your 2024 priorities. Consider these insights when planning your own capital formation and partnering strategies for this year & get a preview of the program and BIO One-on-One PartneringTM tips for the upcoming BIO CEO & Investor Conference, February 26-27.
Speakers include:
-- Donna LaVoice (Moderator), President and CEO, LaVoieHealthScience
-- Evan Loh, MD, CEO, Paratek Pharmaceuticals
-- Kimberly Nearing, Venture Partner, BVCF
·-- Tim Opler, PhD, Managing Director, Global Healthcare Group, Stifel
A new poll finds most Americans want the Biden administration to protect IP rights on the international stage, and both consumers and investors are increasingly interested in products made from captured carbon. (560 words, 2 minutes, 48 seconds)
With a new bipartisan proposal to restore the full R&D tax deduction on the table, now’s the time for you to take action—we tell you how. Plus, five takeaways from BIO’s participation in JPM Week. (599 words, 2 minutes, 59 seconds)
ICYMI: R&D tax deductions are now amortized over five years—but you can take action to help restore R&D tax exemptions and support innovation. New York recently became the first state to regulate the treatment of seeds with neonicotinoids—here’s why it matters. (526 words, 2 minutes, 37 seconds)
Registration and the BIO One-on-One Partnering™ System are now open!
BIO One-on-One Partnering unifies access to partnering for the life science industry. You can efficiently arrange meetings with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders, regardless of whether you are registered for a specific event during JPM Week.
A recent analysis in Health Affairs explains why we need to restore orphan drug incentives, and a new report highlights the toll of the record number of climate-related disasters in the U.S. (433 words, 2 minutes, 9 seconds)
We’re off on Monday in recognition of Martin Luther King Jr. Day. We’ll resume publication on Tuesday, January 16.
Registration and the BIO One-on-One Partnering™ System are now open!
BIO One-on-One Partnering unifies access to partnering for the life science industry. You can efficiently arrange meetings with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders, regardless of whether you are registered for a specific event during JPM Week.
